Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Cancer cells are different from normal cells, as normal cells can result in generation of cancerous cells, when a series of mutations leads the normal cell to continue to grow and divide out of control. Cancer cells have the ability to travel or invade nearby tissues and thus spread to different regions of body, unlike normal cells that remain in the region, where they began. Cancer cells are generated in the human body through a series of genetic and epigenetic changes. Some of these changes may be either inherited or more often, caused by carcinogens (cancer causing substances) such as tobacco and others.

The global cancer cell market is estimated to be valued at US$ 8,525.5 million in 2020 and is expected to exhibit a CAGR of 8.20 % during the forecast period (2020-2027).

Figure 1. Global Cancer Cell Market Value (US$ Mn), 2016-2027

Cancer Cell  | Coherent Market Insights

Increasing prevalence of cancers such as lung cancer, breast cancer, and others is expected to propel growth of the global cancer cell market during the forecast period. For instance, according to the World Health Organization report published in 2018, stated that cancer is the second leading cause of death in people globally and caused around 9.6 million deaths, globally in the year 2018.

Furthermore, key companies focusing on inorganic strategies such as mergers and acquisitions to launch new targeted cell therapies for the treatment of people suffering from cancer, are expected to drive growth of the market. For instance, in 2018, Pfizer, Inc. announced its merger with Allogene to develop an investigational CAR-T cell therapy for the treatment of cancer.

request-sample

Cancer Cell Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 8,525.5 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 8.20 % 2027 Value Projection: US$ 8,525.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Cancer Cell Type: Carcinomas, Sarcomas, Leukemia, Others.
  • By Application: Chemotherapy, Radiation Therapy, Immuno-therapy, Hormone Therapy, Targeted Drug Therapy, Others.
  • By End User: Hospital & Clinics, Specialty Clinics, Diagnostic Laboratories.
Companies covered:

Abbott Laboratories, Novartis International AG, Arcellx, Autolus Therapeutics, Kite Pharma, Cellectis, Celyad Oncology, Crescendo Biologics Limited, GammaDelta Therapeutics Ltd., Bio-Rad Laboratories Inc, QIAGEN Inc, Thermo Fisher Scientific, Merck Millipore, Siemens Healthineers AG, and GE Healthcare.

Growth Drivers:
  • Increasing prevalence of cancers such as head and neck cancer, lung cancer, and breast cancer globally
  • Key players focusing on research and development for the treatment of various cancers
Restraints & Challenges:
  • Stringent regulatory scenario for approval of cancer cell therapies

Global Cancer Cell Market – Impact of Coronavirus (COVID-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency. According to the World Health Organization’s report, manifestation of coronavirus (COVID-19) has resulted in over 67 million infected individuals worldwide as of December 07, 2020.

The coronavirus (COVID-19) pandemic and resulting lockdown in various countries across the globe have impacted the financial status of major companies in cancer cell market. The private healthcare sector is one of the sectors, which has been majorly impacted by the COVID-19 pandemic. The pandemic has negatively impacted the global cancer cell market in various aspects such as research and development, production, and supply of medicines and also affected growth of the pharmaceutical businesses of various companies across the globe due to lockdowns implemented by governments of several countries. The nationwide lockdowns have led to closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the raw materials and drugs for therapeutic use.

Figure 2. Global Cancer Cell Market Share (%), By Region, 2020

Cancer Cell  | Coherent Market Insights

North America is expected to hold dominant position in the global cancer cell market during the forecast period, owing to key companies focusing on inorganic strategies such as mergers and acquisitions for developing the treatment of various cancers such as lung cancer and others. For instance, in August 2020, Siemens Healthineers announced its merger with Varian Medical Systems, a manufacturer of radiation therapy hardware and software to build out its cancer care offerings and provide a screening platform and diagnosis for the better and efficient treatment for cancer.

Key Players

Major players operating in the global cancer cell market include Abbott Laboratories, Novartis International AG, Arcellx, Autolus Therapeutics, Kite Pharma, Cellectis, Celyad Oncology, Crescendo Biologics Limited, GammaDelta Therapeutics Ltd., Bio-Rad Laboratories Inc, QIAGEN Inc, Thermo Fisher Scientific, Merck Millipore, Siemens Healthineers AG, and GE Healthcare.

The global cancer cell market include various therapies used for the treatment of various cancers such as lung cancer, breast cancer, and others. There are various therapies for treatment of cancer such as chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted drug therapy and others. The types of cancer such as carcinomas, sarcomas, leukemia, and others are caused due day to day lifestyles, and or more often, caused by carcinogens (cancer causing substances) such as tobacco etc.

Market Dynamics

Key players are focusing on research and development for treatment of cancers such as small cell lung cancer to strengthen their position in the global cancer cell market. For instance, in December 2019, Roche announced that the U.S. Food and Drug Administration (FDA) approved its Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane) for the initial (first-line) treatment of adults with metastatic non-squamous non-small cell lung cancer (NSCLC) with no epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) genomic tumor aberrations.

Key features of the study:

  • This report studies the current scenario as well as the future potential of the global cancer cell market. The market for cancer cell market is segmented on basis of cancer cell type, application, end user, and region.
  • This report provides in-depth analysis of the global cancer cell market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
  • It profiles leading players in the global cancer cell market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global cancer cell market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global cancer cell market

Detailed Segmentation:

  • Global Cancer Cell Market, By Cancer Cell Type:
    • Carcinomas
    • Sarcomas
    • Leukemia
    • Others
  • Global Cancer Cell Market, By Application:
    • Chemotherapy.
    • Radiation Therapy
    • Immunotherapy
    • Hormone Therapy
    • Targeted Drug Therapy
    • Others
  • Global Cancer Cell Market, By End User :
    • Hospitals & Clinics
    • Specialty Clinics
    • Diagnostic Laboratories
  • Global Cancer Cell Market, By Region:
    • North America
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Novartis International AG
    • Arcellx
    • Autolus Therapeutics
    • Kite Pharma
    • Cellectis
    • Celyad Oncology
    • Crescendo Biologics Limited
    • GammaDelta Therapeutics Ltd.
    • Bio-Rad Laboratories Inc
    • QIAGEN Inc
    • Thermo Fisher Scientific
    • Merck Millipore
    • Siemens Healthineers AG
    • GE Healthcare   

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Cancer Cell Type
      • Market Snapshot, By Application 
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Impact Analysis
    • Key Developments
    • New Product Launches/Approvals
    • Merger-Acquisition Scenario
    • Regulatory Scenario
    • Pipeline Analysis
    • Epidemiology
    • PEST Analysis
    • Reimbursement
  4. Global Cancer Cell Market - Impact of COVID-19 Pandemic
    • Government Initiative To Combat Covid-19
    • COVID 19 Impact on Cancer Patients
    • COVID 19 Impact on Oncology Treatment
  5. Global Cancer Cell Market, By Cancer Cell Type, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Carcinomas
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Sarcomas
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Leukemia
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  6. Global Cancer Cell Market, By Application, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Chemotherapy.
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Radiation Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Immunotherapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Hormone Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Targeted Drug Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  7. Global Cancer Cell Market, By End User, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Hospitals & Clinics
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Specialty Clinics
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Diagnostic Laboratories
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  8. Global Cancer Cell Market, By Region, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Germany
        • U.K.
        • France       
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016–2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis International AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Arcellx
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Autolus Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kite Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cellectis
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Celyad Oncology
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Crescendo Biologics Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GammaDelta Therapeutics Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • QIAGEN Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Thermo Fisher Scientific
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck Millipore
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthineers AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GE Healthcare   
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 33 market data tables and 32 figures on " Cancer Cell Market – Global forecast to 2027”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.